Synergistic Effects And Mechanism Of Danshen Injection In Combination With Chemotherapy And Antiangiogenic Therapy For Colon Cancer
Zhonghai Guan,Huanrong Lan,Xiangheng Chen,Xiaoxia Jiang,Zhongqi Li,Xiongfei Yu,Jiang Cao,Ketao Jin,Lisong Teng
2017-01-01
Abstract:Cancer-associated hypercoagulation is a negative factor for anticancer treatment. Anticoagulant therapy might reverse the treatment bottleneck. The efficacy of Danshen injection in combination with chemotherapy and anti-VEGF targeted therapy was evaluated based on a previously established colon carcinoma patient-derived xenografts (PDXs). Immunohistochemistry and pharmacological experiments were conducted to explore the mechanism underlying the synergistic effects of Danshen. Finally, Danshen injection shown significant synergistic effect in combination with bevacizumab and Eloxatin. After Danshen injection combination treatment, hypoxia markers CAIX, GLUT1 and VEGF were suppressed, immunofluorescence expressions of fibrosis markers (PDGF-beta, TGF-beta, TIMP1 and desmin) were suppressed, and tumor vasculatures (visualized by CD31 and alpha-SMA immunostaining) shown more normalization. In addition, no tumor distant metastases (such as, liver, spleen, kidney, lung and brain) were found. In conclusion, we first reported Danshen injection as a novel efficient combination therapy with chemotherapy and anti-VEGF therapy for treatment of metastatic colon carcinoma through several possible mechanisms of improving drug distribution, such as by improving tumor hypercoagulable state and blood flow, by alleviating the tumor stroma fibrosis state, and by enhancing the tumor vasculature normalization effect of anti-VEGF therapy. In addition, Danshen injection showed no side effect of tumor distant metastases.